Skip to main content
Equibles

ACADIAN ASSET MANAGEMENT LLC

Position in ATNM — Actinium Pharmaceuticals, Inc.

CIK 916542 Boston, MA
Back to ATNM Full portfolio

Position in ATNM

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$486,362
-$111,452 QoQ
Shares Held
496,288
-17.4% QoQ
Ownership
1.58%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#4
of 47 holders
Holding Since
Sep 2022
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ATNM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ACADIAN ASSET MANAGEMENT LLC holds $732,389,014 across 168 Biotechnology names. ATNM ranks #89 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INCY
Incyte Corp
 1,664,999 $188,744,286
2 REGN
Regeneron Pharmaceuticals, Inc.
 157,440 $98,170,137
3 IMCR
Immunocore Holdings plc
 1,209,894 $38,414,134
4 RIGL
Rigel Pharmaceuticals Inc
 591,686 $23,146,756
5 EXEL
Exelixis, Inc.
 421,444 $22,930,768
6 VRTX
Vertex Pharmaceuticals Inc / Ma
 42,122 $20,923,261
7 TBPH
Theravance Biopharma, Inc.
 1,174,910 $19,973,470
8 PRTA
Prothena Corp Public Ltd Co
 2,010,645 $19,684,214

All Filings in ATNM

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $486,362 496,288
2026-03-31 $597,814 600,819
2025-12-31 $824,621 606,339
2025-09-30 $783,323 489,577
2025-06-30 $688,720 491,943
2025-03-31 $811,501 504,038
2024-12-31 $629,067 499,260
2024-09-30 $852,944 453,694
2022-12-31 $273,630 25,693
2022-09-30 $116,330 15,763